Glenmark Pharmaceuticals said its overseas subsidiary has discovered a molecule that can potentially be used in targeting even difficult-to-treat lung cancer and colorectal cancer. The GBR 1372 molecule was discovered in the pharma company’s Swiss laboratory and that the company plans to file an application with the US Food and Drug Administration to approve the […]
The US Food & Drug Administration issued a warning against casual usage of fluoroquinolone antibiotics, arguably the most widely used broad-spectrum antibiotic in India. USFDA advised that the side effects caused by the use of fluoroquinolone antibacterial drugs would outweigh the benefits for patients who have alternative treatment options. Patients with acute sinusitis, acute bronchitis and uncomplicated urinary […]
Ministry of Ayush, government of India signed a memorandum of understanding (MOU) with United States Pharmacopeial Convention for cooperation in the field of traditional medicine. The aim is to promote the safety, quality and integrity of traditional medicines and botanical dietary supplements, the government said. The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization […]
Lupin Ltd announced today that it has received approval to launch Acotiamide 100 mg indigestion tablets in India from the Central Drugs Standard Control Organization. Acotiamide is a drug to be introduced into the Indian Pharmaceutical Market which could benefit millions of patients suffering from Dyspepsia or Indigestion, most common stomach complaints encountered in clinical […]
The Health Ministry will soon come out with a National Injury Control Program to provide health care and save lives of the lakhs of persons lost in accidents and to injury, announced health minister J P Nadda, while inaugurating the Third World Trauma Congress today. “Road traffic injuries are among the three leading causes of […]
Glenmark Pharmaceuticals has announced the discovery of a new anti-cancer therapy by its Swiss subsidiary. The new drug, GBR 1302, will target breast cancer and ovarian cancer, and the company expects to start clinical studies this year. Unlike normal drugs, the new drug will work by making it easier for human body’s defence mechanism, white […]
